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In  vivo, the elimination of soluble  antigen-antibody (AgAb) 1 complexes by the 
reticuloendothelial system is apparently independent of complement  (1). This con- 
trasts  with  the  promoting effect of complement on the phagocytosis of Ab-coated 
particles. In this case, C3 and IgG act in synergy. IgG, by reacting with Fc-receptors, 
stimulates particle ingestion, but is relatively inefficient at inducing particle binding. 
C3 mediates the binding of the particle to the phagocyte without direct stimulation 
of the ingestion (2). The present work deals with the opsonie activity of complement 
on soluble material, and reports the following two observations. First, in contrast to 
what  has been  observed  in  vivo, complement  markedly promotes the ingestion by 
mouse peritoneal macrophages  (MPM)  of soluble AgAb complexes containing IgG 
antibodies. However, with t25I-labeled  complexes, this effect is evident only when the 
release of degradation products is considered. Using 59Fe-labeled  human transferrin 
(Tf)  as Ag in  the complexes, it  is  possible to demonstrate directly the  increase of 
uptake induced by complement because, as it will be shown, ~9Fe is not released from 
the macrophage~ after digestion of its carrier. Second, contrasting with the results 
obtained  with  IgM-coated  particles  (2),  soluble  heat-aggregated  human  IgM  is 
ingested in significant amounts in the presence of complement, indicating that the 
endocytosis of soluble material, in contrast to particles, does not necessarily require 
the involvement of Fc receptors. 
Materials and Methods 
Cells.  Nonstimulated  macrophages  were  collected  from  the  peritoneal  cavity  of normal 
female NMRI mice. In some experiments,  129/Sv mice maintained  under specific pathogen- 
free  conditions  were  used.  The  cells were  processed  as  previously  described  (3)  with  slight 
modifications. Briefly, a  10-ml vol of basal medium of Eagle (BME) containing 20 U of heparin 
per milliliter was injected into the peritoneal cavity, and reaspirated after abdominal kneading. 
After centrifugation,  the cells were resuspended in BME containing 20% heat-decomplemented 
fetal calf serum (FCS), 50 U/ml penicillin, and 50 ~g/ml streptomycin. About 3.10  s cells were 
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seeded  per well in Sterilin tissue culture plates (Teddington, Middlesex, Great Britain). After 
about a  l-h incubation at 37°C in a  10% CO2 atmosphere, the adherent macrophages (5-7.105 
cells per well) were washed free of other cells with BME, and reincuhated with the appropriate 
medium. 
Reagents.  Human iron-free Tf was from Behring Institute (Marburg/Lahn, West Germany). 
Antiserum  against  Tf  (ATt)  was  obtained  from  NMRI  mice  after  weekly  subcutaneous 
injections of 100/~g of antigen suspended in complete Freund's adjuvant. For labeling Tf, the 
protein, dissolved  in phosphate-buffered saline (PBS) containing  0.05 M NaHCO3, was mixed 
with [59Fe]citrate in sufficient amounts to saturate the protein up to 80% of its iron-binding 
capacity.  Tf-ATf complexes were  prepared  in 3-,  5-,  and  10-fold Ag excess by adding the 
appropriate  amount of heat-decomplemented mouse  antiserum to  labeled Tf.  After  a  l-h 
incubation at 37°C, the complexes were left for 3 days at 4°C before use. Even, after 3 wk, no 
precipitate was visible. The amount of Tf bound by the anti-Tf antibodies was measured for 
each  preparation  of  immune complexes  by  density  gradient  ultracentrifugation (4). The 
distribution of complexes was as follows. For the preparation in threefold Ag excess, 13% of the 
complexes sedimented as a  13.5 S peak, 30% as a polydisperse fraction (13.5-30 S), and 57% 
were  concentrated in the  pellet  (>30 S).  For the  preparation in 5-  and  10-fold Ag excess, 
respectively, 27 and 34% were in the 13.5 S peak, 45 and 50% in the polydisperse fraction, and 
30 and 16% in the pellet. 
A human IgM monoclonal component was kindly provided by Dr. J. P. Vaerman (Univer- 
sit~ Catholique de Louvain, Brussels, Belgium), and aggregated by heating at 63°C for 30 min. 
After such treatment, the preparation was slightly opalescent, but no precipitate was visible. In 
gradient ultracentrifugation, all the aggregates were  recovered in the pellet corresponding to 
material of >30 S. No IgG (<0.1% of the protein content) was detected in the IgM solution by 
immunonephelometry (AIP system, Technicon Instruments Corp., Tarrytown, N. Y.). 
As a source of complement, we used fresh  NMRI serum (FMS) or guinea pig serum. The 
sera were decomplemented by heating at 56°C for 30 min, by incubation with zymosan (20 mg 
boiled zymosan per milliliter of serum, 2 h at 37°C), or with hydrazine (5). Human IgM and 
human Tf were labeled with 12sI by the chloramine T method. 
Methods.  To measure the amount of immune complexes or IgM aggregates associated with 
MPM, the radioactivity was counted on the cellular extracts obtained by  1% Triton X-100 
(Robin & Haas Co., Philadelphia, Pa.), the value being corrected for the radioactive material 
in the absence of cells. Before extraction, MPM were washed once with 3 ml and twice with 1 
ml PBS, and then counted under the inverted microscope. 
The degradation  products  released  by  the  cells  into the  medium were  recovered  in the 
supernate of the culture medium after precipitation of proteins by  10% trichloroacetic acid 
(TCA). The TCA-soluble radioactivity was corrected  by subtracting the  value obtained in 
controls consisting of the supernates of the culture medium precipitated by TCA after having 
been incubated with the radioactive material in the absence of cells. 
To check whether MPM were activated or not, experiments with sheep-erythrocytes coated 
with IgM antibodies and complement (E-IgM-C) were done following a method similar to that 
used by Bianco et al. (6). A 10% suspension of sheep erythrocytes was incubated at 37°C for 30 
min with a  subagglutinating concentration of mouse IgM antibodies prepared as described 
hereafter.  After  two  washings with  PBS,  the  IgM-coated  cells  were  resuspended  in  BME 
containing 20%  FMS  which  had  previously been  absorbed  with  sheep  erythrocytes,  and 
incubated for  30  min at  37°C.  The cells  were  washed  again twice with  PBS,  and finally 
resuspended in BME before their addition to MPM. IgM antibodies against erythrocytes had 
been isolated from the mouse anti-sheep erythrocytes serum by gel filtration on Uhrogel AcA 
34  (LKB,  Bromma,  Sweden)  followed  by affinity chromatography on  protein A-Sepharose 
(Pharmacia, Uppsala, Sweden)  for  retaining the  residual IgG molecules.  Trace amounts of 
IgG2b antibodies were removed by passage on a column of insolubilized rabbit anti-IgG2b (7). 
Before counting the erythrocytes ingested by MPM, the latter were washed thrice with PBS, 
and the  noningested erythrocytes lysed  by a  45-s contact with hypotonic solution (fivefold 
diluted PBS).  The monolayer was then fixed with 5% glutaraldehyde before examination by 
phase-contrast microscopy. 
For the fluorescence  study, the antigen of the immune complexes i.e., human Tf was labeled 
with fluorescein isothiocyanate. The MPM  from  129/Sv mice were  cultured in dishes  3001 J.  L.  VAN  SNICK  AND  P.  L.  MASSON  905 
from Falcon Plastics (Division of BioQuest, Oxnard, Calif.)  for 1 h in the presence of the labeled 
complexes in threefold Ag excess, with fresh or heated mouse serum. After three washings with 
medium at  37°C, the cells were examined under a cover slip with an ultraviolet microscope. 
Results 
The Effect of Complement on the Uptake and Digestion of AgAb Complexes.  MPM  were 
incubated  for  various  times  with  t25I-Tf-ATf complexes  (5  #g  Ab/ml)  in  BME 
containing 20%  FMS or mouse serum  decomplemented  by heating  (HMS).  After a 
slight increase during the first 3 h, more evident with FMS, the radioactivity associated 
with the cells remained almost constant  (Fig.  1, lower panel). 
When the degradation products detected in the medium as TCA-soluble  lzsI were 
considered, their rate of appearance after incubation with FMS was about four times 
higher than  after  incubation  with  HMS  (Fig.  1, upper panel, and Table I). Similar 
results were obtained with AgAb complexes which contained labeled Ab rather than 
labeled Ag (data not shown). 
After 2.5 h, the radioactivity associated with  105 MPM  remained  almost constant 
at a value representing 0.185% of the complexes per milliliter medium after incubation 
with complement, and 0.049% after incubation without complement. When expressed 
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FIG.  1.  The effect of FMS on the uptake of 12~l-labeled Tf-anti-Tf complexes by MPM (lower 
panel) and on the release of degradation  products from ~25I-Tf  (upper panel). The results were 
expressed in percents of the AgAb complexes per milliliter of medium. Vertical bars represent 1 SD 
calculated from triplicate experiments. 906  THE EFFECT OF COMPLEMENT ON SOLUBLE COMPLEXES 
TAnLE I 
Comparison of the Rates of Uptake of ~SFe-  Tf-A Tf Complexes by MPM and 
the Rates of Release of Degradation Products of 125I-  Tf-A Tf Complexes 
Conditions of in- 
cubation  Rate of uptake*  Rate of release:[: 
With FMS  0.182 (SD ffi 0.009)  0.228 (SD -  0.033) 
With HMS  0.058 (SD ffi 0.007)  0.065 (SD -- 0.016) 
* (r~Fe associated with l0  s MPM)/([r~Fe-Tf-ATf/ml  medium]h) ×  100. 
(TCA soluble 125I released by 10  ~ MPM)/([lmI-Tf-ATf/ml  medium]h) × 
100. 
respectively, 123 and  133%/h in the experiments done with and without complement. 
Hence, the digestion rates did not differ significantly, as confirmed by the study of 
the half-lives of complexes in MPM described later. 
To  see  whether  the  effects  of FMS  could  be  due  to  an  enhancement  of the 
extracellular proteolysis of the complexes, MPM were incubated in BME containing 
20% FMS or HMS. After 8 h, this medium was recovered and reincubated for l0 h 
at 37°C with .125I-Tf-ATf complexes in the absence of cells.  Extracellular proteolysis 
was calculated from the difference of the TCA-soluble radioactive material recovered 
from this medium and from control medium not preincubated with cells.  In  1 ml of 
medium  corresponding to a  culture  of 105 MPM,  only 0.15  and  0.16%  of the  Ab- 
associated Tf was  digested  by extracellular  proteolysis in  the  presence of HMS or 
FMS, respectively. 
The endocytosis experiments with  125I-Tf-ATf complexes  (50/tg Ab/ml medium) 
were repeated with BME containing 20% guinea pig serum as a source of  complement. 
The same results as with mouse serum were obtained. To ascertain that complement 
acted via C3 and not via C1, which could increase the size of the complexes, guinea 
pig serum was treated with zymosan or hydrazine which affect C3 without interfering 
with C l. Similar results were obtained with zymosan- or hydrazine-treated serum as 
with heated serum  (Fig.  2). 
The  Effect  of Complement on the Half-Life  of AgAb  Complexes in MPM.  After  a  2-h 
incubation with 125I-Tf-ATf  complexes in the presence of FMS or HMS, MPM were 
washed and reincubated, in the absence of AgAb complexes, in BME containing 20% 
decomplemented FCS.  After various times,  the  radioactivity remaining in  the cells 
was  measured  (Fig.  3).  No  difference  was  observed  in  the  decay of radioactivity, 
between the two incubation conditions, i.e., in the presence or absence of complement. 
In both cases,  after  1 h, 220% of the initial radioactivity was released from the cells, 
a  value  differing  markedly  from  that  estimated  earlier  in  the  experiment  with 
continuous feeding of MPM with complexes (120-130%/h). This difference could be 
due  to  handling of the  cells.  In the  half-life experiment,  the  repeated  washings  at 
room temperature  altered  the morphology of MPM,  which lost  their characteristic 
spread pattern and acquired a round shape. Presumably, the metabolic activity of the 
cells  was also modified, which could explain  the  decreased  digestion  and  excretion 
rate of the ingested material. 
Effect  of Complement on  the  Ingestion of AgAb  Complexes Containing  Tf Labeled with 
~gFe.  MPM  were incubated with 59Fe~Tf-ATf complexes in threefold Ag excess  for 
17 h  with or without complement. After washing, the cells  were reincubated,  in the 
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FIG.  2.  Excretion rate of digestion products  of immune complexes which  had  been  ingested by 
MPM  in the presence of guinea pig serum, fresh or decomplemented by heating or incubation with 
zymosan or hydrazine. Vertical bars represent  1 SD calculated from triplicate experiments. 
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Fro.  3.  Elimination of degradation products of l~I-labeled Tf-anti-Tf complexes by MPM  after 
ingestion in the presence of FMS  (O)  or HMS  (0).  Vertical bars represent  I  SD calculated from 
triplicate experiments. 
significant  decay of the  radioactivity of the cells was observed over a  26-h  period, 
whether the incubation had been in the presence or absence of complement (Fig. 4). 
Hence,  the  radioactivity  of the  cells  corresponded  to  the  total  amounts  of AgAb 
complexes that had been picked up, and the effect of complement could be measured 908  THE  EFFECT  OF  COMPLEMENT  ON  SOLUBLE  COMPLEXES 
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Fxo.  5.  Uptake of ~SFe-Tf-anti-Tf complexes by MPM in the presence of FMS or HMS. Note the 
point  (B)  corresponding to the uptake of 59Fe-Tf free of antibody. Vertical  bars represent  1 SD 
calculated from triplicate experiments. 
directly (Fig. 5). With complement, the rate of uptake was found to be about three 
times  faster than without.  The extrapolation of the uptake regression lines to zero 
time indicated that, with complement, 105 MPM instantaneously bound 0.3% of the 
complexes present in  1 ml medium and, without complement, <0.01%. 
No significant difference (Table I)  was  found between the uptake rates of AgAb 
complexes calculated in the experiment with 59Fe-Tf-ATf complexes (Fig. 5) or from 
the release of degradation products of 125I-Tf-ATf complexes (Fig.  1). 
When complexes in 5- or 10-fold Ag excess were used for the uptake experiments, 
the enhancing effect of complement was still clearly visible (Table II). However, with J.  L. VAN SNICK AND P.  L.  MASSON 
TABLE II 
Uptake of SSFe-TF-A  Tf Complexes by MPM 
909 
Rate of uptake* (slope +  SD)  Instantaneous binding (intercept) 
AgAb complexes  Without  With  Without  With 
complement  complement  complement  complement 
3-Fold Ag excess  0.058 (0.007)  0.182  (0.009)  <0.01  0.300 
5-Fold Ag excess  0.014 (0.006)  0.051 (0.013)  0.004  0.107 
10-Fold Ag excess  0.004 (0.002)  0.012 (0.006)  0.008  0.044 
* (~Fe associated with 10  s MPM)/([~Fe-Tf-ATf/ml medium]h) ×  100. 
such excess of 5aFe-Tf, it was found necessary to correct the results for the uptake of 
free Ag. This was done in control experiments performed with 5aFe-Tf alone. 
To see whether the 5aFe-Tf-ATf complexes were ingested or just bound to the cell 
surface, MPM were treated with trypsin which is known to destroy C3-receptors (8). 
After various  incubation  times with  the  immune complexes, the cells were washed 
twice with 2 ml BME, and reincubated for 30 rain at 37°C in BME with or without 
0.5 mg/ml trypsin. Such treatment did not decrease significantly the radioactivity of 
the cells.  As the trypsin treatment was repeated after different  incubation  times, it 
was possible to calculate the rate of uptake. This was 0.194% of the complexes in 1 ml 
medium/h (SD  =  0.013), a value not significantly different from that obtained in the 
experiments done without trypsin (0.212%/h,  SD  -- 0.015). 
In  control  experiments,  MPM  were  exposed  first  to  trypsin  for  30  min  before 
incubation  with the immune complexes. In such conditions  the enhancing effect of 
complement was abolished. After a  30-min incubation with complexes, the radioac- 
tivity associated with  the  cells  reached  only 6%  of the  expected  value.  It  must  be 
noted that  trypsin did  not  affect the 5aFe-Tf-ATf complexes, as shown by gradient 
ultracentrifugation. 
The ingestion of the complexes was confirmed by fluorescence data. After incuba- 
tion  with  immune  complexes  containing  fluorescein-labeled  Tf for  1  h,  nonfixed 
MPM  showed large cytoplasmic patches of fluorescein  (Fig. 6, A). The intensity of 
fluorescence was markedly lower in MPM incubated with complexes in the absence 
of complement (Fig. 6, B). 
Effect of Complement on the Uptake ofl25I-Labeled Aggregated Human IgM by MPM.  MPM 
were incubated  with  l~I-labeled heat-aggregated IgM  (5/.tg/ml)  in the presence or 
absence  of complement  (20%  fresh  or  heated  guinea  pig  serum).  As  a  source  of 
complement,  we used  guinea  pig serum  rather  than  mouse serum  as  human  IgM 
aggregates were apparently unable to activate mouse complement. The radioactivity 
of the  cells  increased  faster in  the  presence of complement.  Significant  differences 
were already observed after 30 min.  After 3  h,  the radioactivity tended  to become 
constant in the absence of complement (Fig.  7, lower panel). 
The effect of complement was particularly evident when the release of degradation 
products was considered.  Its rate was m22 times higher than  after incubation  with 
heated guinea pig serum (Fig. 7, upper panel). 
To check whether aggregated IgM had been ingested and not digested at the cell 
surface, MPM having been exposed to 125I-IgM aggregates were treated with trypsin 
to destroy C3-receptor. MPM were incubated with  l0/Lg/ml t25I-IgM aggregates in 
the presence or absence of complement (20% fresh or heated guinea pig serum). After 910  THE  EFFECT OF  COMPLEMENT  ON  SOLUBLE COMPLEXES 
Fro.  6.  MPM after  1 h  incubation with Tf-anti-Tf complexes  in  threefold  Ag excess containing 
fluorescein-labeled  Tf.  (A)  After incubation  with fresh  mouse serum.  (B)  After incubation  with 
heated mouse serum.  X  400. 
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various times,  the cells were washed with PBS, and  then  reincubated  at  37°C  for 30 
min  in  BME  with  or  without  0.5  mg/ml  trypsin.  The  amount  of  radioactivity 
associated with the cells at  various time intervals indicated  that  ~50% of the material 
bound  to the cells in the presence  of complement  was  ingested,  the rest  being at  the J.  L.  van  SNICK  AND  P.  L.  MASSON  911 
0.6 
z_ 
z  ~.  0.5 
C]  ~  o~ 
~o'~-~  "'°,,,o .~  ..~  •  ~, 0s  /wit. oo~pt.=..~  -F/~ 
,.n-  0.2 
~  ]t:  ~  without  complement 
1  2  3  t.  5 
HOURS 
PIG. 8.  Effect of trypsin treatment of MPM on the uptake of ]25[-labeled heat+aggregated human 
IgM  in  the  absence  or  presence  of fresh  guinea  pig  serum  as  a  source  of complement.  After 
incubation for various times with *2~I-IgM aggregates with or without complement, the cells were 
reincubated with or without  trypsin for 30 min. After appropriate  washings the radioactivity of 
these cells  was  measured.  The  uptake  after  incubation  without  complement  but  after  trypsin 
treatment is indicated by C). Bars represent  1 SD calculated from triplicate experiments. 
cell  surface  (Fig.  8).  Trypsin  released  the  IgM  aggregates  from  the  cell  surface 
probably  by  digesting  the  IgM  itself  as  well  as  the  C3  receptors,  as  gradient 
uhracentrifugation of trypsin-treated l~I-IgM-aggregates showed complete digestion 
of the protein: all the radioactivity remained at the top of the gradient. 
Controls of the Nonactivated State of MPM.  To exclude the possibility that the cells 
used for the experiments were activated macrophages, the experiments with aggre- 
gated IgM were repeated on MPM collected from 129/Sv mice maintained in specific 
pathogen-free conditions. The results were similar to those obtained with conventional 
mice. 
Further proof that these MPM were not activated was provided by the fact that E- 
IgM-C attached to macrophages but were not ingested. MPM from 129/Sv mice were 
incubated  in  BME  with  E-IgM  or  E-IgM-C  prepared  as  described  in  Materials 
and Methods. After 1 h at 37°C, appropriate washing, and osmotic lysis of noningested 
erythrocytes, those ingested by MPM were counted by phase-contrast  microscopy. 
The number of E-IgM-C attached to 100 MPM was 638 (°r  33), whereas the number 
of ingested E-IgM-C was 9 (°r  3). No ingested E-IgM was detected. 
Discussion 
The present work shows that complement enhances the ingestion of soluble AgAb 
complexes in various Ag excess by MPM. With 125I-labeled complexes, this activity 
became evident only when the release of degradation products was measured. When 
the  complexes were  labeled  with 59Fe, using Tf as  Ag,  the  uptake  was  measured 
directly as the metal was not excreted by the cells. 
The fast elimination of degradation products by MPM after incubation of immune 
complexes with complement raised the question of a  possible role of complement in 912  THE EFFECT OF COMPLEMENT ON SOLUBLE COMPLEXES 
their intracellular digestion. By stimulating the digestion, complement could indirectly 
accelerate the ingestion. Comparing the half-lives of complexes after their uptake by 
MPM in the presence or absence of complement did not show any difference. This 
suggested that complement did not promote the digestion. 
That this digestion occurred inside the macrophages was indirectly shown by the 
weak proteolytic activity of the medium having been in contact with MPM, and by 
the  lack  of effect  of trypsin  added  after  the  cellular  uptake  of complexes.  This 
observation suggests that the complexes were not anymore on the cell surface but 
were already ingested when the trypsin was added. However, it was possible that the 
C3-receptors became unaccessible to trypsin when bound to the complexes. So, we 
checked the ingestion of complexes by fluorescence. This confirmed that complement 
did promote the endocytosis. 
Our results contrast with the observation of Mannik and Arend (1) who reported 
that, in vivo, the clearance of AgAb complexes was independent of complement. This 
discrepancy could be explained by the great difference in the proportion of complexes 
vs. phagocytes in the two experimental systems. On one hand, the amount of immune 
complexes injected by Mannik and Arend being much lower than the phagocytic 
capacity of the reticuloendothelial system of the animals, the complexes were cleared 
so fastly through Fc-receptors that the complement could not accelerate the process. 
On the other hand, in our in vitro experiments, the number of cells being restricted, 
the opsonic activity of complement became evident. The in vivo experiments consisted 
of a single injection of immune complexes, whereas in pathological conditions such as 
infections, Ag are released and immune complexes produced in a continuous way. In 
such a  situation, the clearance of complexes is presumably facilitated by C3. One 
could then wonder why immune complexes that contain (23 persist in the blood of 
patients with various diseases (9,  10). We suppose that, in fact, these complexes are 
eliminated but continuously replaced because of the permanent supply of Ag. 
Our second observation dealt with the stimulating activity of complement on the 
ingestion of IgM-aggregates. Ehlenberger and Nussenzweig (2) reported that comple- 
ment enhanced the adherence of IgM-coated erythrocytes but not their ingestion. The 
endocytosis occurred only when the particles were attached to the Fc-receptor alone 
or to both Fc- and C3-receptors. In our work, complement did promote the attachment 
of IgM-aggregates, but also their ingestion. 
Bianco et al. (6) have shown that macrophages activated by endotoxin or thiogly- 
colate are capable of ingesting C3-coated particles without binding to Fc-receptors. 
So, our results could perhaps be explained by the activation of macrophages because 
of some latent infections of the animals. This was unprobable as the cells did not 
show any morphological signs of activation and did not ingest erythrocytes coated 
with IgM antibodies and complement. 
The differences between the fates of particulate and soluble complexes could be 
explained by the fact that ingestion of particles requires more important modifications 
of the phagocyte membrane than does the ingestion of soluble complexes. Experiments 
with  cytochalasin indicate  that  ingestion  via  Fc-receptors  requires  the  functional 
integrity of microfilaments, whereas C3-mediated endocytosis would be less dependent 
on motile structures (11).  Hence, nonactivated macrophages could ingest (23-coated 
material, provided it is soluble. 
We have shown elsewhere that optimal concentrations of rheumatoid factor pro- J.  L. VAN SNICK  AND  P. L.  MASSON  913 
mote, in the absence of complement, the endocytosis of IgG-containing complexes. In 
excess, it prevents their ingestion presumably by hiding the Fc regions of IgG (12).  As 
IgM-rheumatoid factor is detected  in large excess in many diseases with circulating 
AgAb  complexes,  it  appears  now  likely  that  these  complexes  coated  with  IgM- 
rheumatoid factor can be ingested by macrophages through their C3-receptors. 
Summary 
Complement  was  found  to  stimulate  markedly the  ingestion  of soluble  antigen- 
antibody complexes by mouse peritoneal macrophages. This was shown indirectly by 
measuring the release of degradation products when the complexes were labeled with 
x~I, or directly when the antigen, that was human transferrin, was labeled with 59Fe. 
In this case, the metal which was released from human transferrin inside the cells was 
not  excreted,  and  its  accumulation  in  the  macrophages was  a  direct  index  of the 
uptake  of  immune  complexes.  The  decay  of  radioactivity  in  macrophages  after 
ingestion  of l~I-labeled complexes was  similar  when  they  were  taken  up  with  or 
without complement, indicating that complement acts primarily on ingestion and not 
on digestion or excretion. The ingestion of complexes was morphologically confirmed 
using fluorescein-labeled antigen in the immune complexes. 
The opsonic effect of complement was also observed with IgM aggregates indicating 
that  soluble  complexes  can  be  ingested  through  complement  receptors  without 
involvement of Fc-receptors, as required for particulate antigen-antibody complexes. 
The authors wish to thank G. Kalmes, B. de Lestr~, and M. Stevens for their excellent technical 
assist  ance. 
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